221 related articles for article (PubMed ID: 9291318)
1. Identification of cross-reactive antibodies with low opsonophagocytic activity for Streptococcus pneumoniae.
Nahm MH; Olander JV; Magyarlaki M
J Infect Dis; 1997 Sep; 176(3):698-703. PubMed ID: 9291318
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of antibody responses to pneumococcal vaccines with ELISA and opsonophagocytic assay.
Kim KH; Seoh JY
J Korean Med Sci; 1999 Oct; 14(5):475-9. PubMed ID: 10576141
[TBL] [Abstract][Full Text] [Related]
3. Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants.
Yu X; Gray B; Chang S; Ward JI; Edwards KM; Nahm MH
J Infect Dis; 1999 Nov; 180(5):1569-76. PubMed ID: 10515817
[TBL] [Abstract][Full Text] [Related]
4. Identification of a simple chemical structure associated with protective human antibodies against multiple pneumococcal serogroups.
Park S; Parameswar AR; Demchenko AV; Nahm MH
Infect Immun; 2009 Aug; 77(8):3374-9. PubMed ID: 19451241
[TBL] [Abstract][Full Text] [Related]
5. Avidity, potency, and cross-reactivity of monoclonal antibodies to pneumococcal capsular polysaccharide serotype 6B.
Sun Y; Hwang Yi; Nahm MH
Infect Immun; 2001 Jan; 69(1):336-44. PubMed ID: 11119522
[TBL] [Abstract][Full Text] [Related]
6. Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants.
Väkeväinen M; Eklund C; Eskola J; Käyhty H
J Infect Dis; 2001 Sep; 184(6):789-93. PubMed ID: 11517443
[TBL] [Abstract][Full Text] [Related]
7. Pneumococcal capsular polysaccharide preparations may contain non-C-polysaccharide contaminants that are immunogenic.
Yu X; Sun Y; Frasch C; Concepcion N; Nahm MH
Clin Diagn Lab Immunol; 1999 Jul; 6(4):519-24. PubMed ID: 10391854
[TBL] [Abstract][Full Text] [Related]
8. Efficiency of a pneumococcal opsonophagocytic killing assay improved by multiplexing and by coloring colonies.
Kim KH; Yu J; Nahm MH
Clin Diagn Lab Immunol; 2003 Jul; 10(4):616-21. PubMed ID: 12853394
[TBL] [Abstract][Full Text] [Related]
9. Cross-reacting opsonic antibodies to clinically important pneumococcal serotypes after pneumococcal vaccination.
Braconier JH; Myhre EB; Odeberg H
Eur J Clin Microbiol; 1983 Oct; 2(5):453-8. PubMed ID: 6641723
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of multiplex flow cytometric opsonophagocytic assays for determination of functional anticapsular antibodies to Streptococcus pneumoniae.
Martinez JE; Clutterbuck EA; Li H; Romero-Steiner S; Carlone GM
Clin Vaccine Immunol; 2006 Apr; 13(4):459-66. PubMed ID: 16603613
[TBL] [Abstract][Full Text] [Related]
11. Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B.
Saeland E; Jakobsen H; Ingolfsdottir G; Sigurdardottir ST; Jonsdottir I
J Infect Dis; 2001 Jan; 183(2):253-260. PubMed ID: 11110649
[TBL] [Abstract][Full Text] [Related]
12. Specificities and opsonophagocytic activities of antibodies to pneumococcal capsular polysaccharides in sera of unimmunized young children.
Soininen A; Karpala M; Wahlman SL; Lehtonen H; Käyhty H
Clin Diagn Lab Immunol; 2002 Sep; 9(5):1032-8. PubMed ID: 12204955
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and efficacy of Streptococcus pneumoniae polysaccharide-protein conjugate vaccines against homologous and heterologous serotypes in the chinchilla otitis media model.
Giebink GS; Meier JD; Quartey MK; Liebeler CL; Le CT
J Infect Dis; 1996 Jan; 173(1):119-27. PubMed ID: 8537648
[TBL] [Abstract][Full Text] [Related]
14. Contribution of serotype-specific IgG concentration, IgG subclasses and relative antibody avidity to opsonophagocytic activity against Streptococcus pneumoniae.
Anttila M; Voutilainen M; Jäntti V; Eskola J; Käyhty H
Clin Exp Immunol; 1999 Dec; 118(3):402-7. PubMed ID: 10594558
[TBL] [Abstract][Full Text] [Related]
15. Correlation of opsonophagocytosis and passive protection assays using human anticapsular antibodies in an infant mouse model of bacteremia for Streptococcus pneumoniae.
Johnson SE; Rubin L; Romero-Steiner S; Dykes JK; Pais LB; Rizvi A; Ades E; Carlone GM
J Infect Dis; 1999 Jul; 180(1):133-40. PubMed ID: 10353871
[TBL] [Abstract][Full Text] [Related]
16. L-rhamnose is often an important part of immunodominant epitope for pneumococcal serotype 23F polysaccharide antibodies in human sera immunized with PPV23.
Park S; Nahm MH
PLoS One; 2013; 8(12):e83810. PubMed ID: 24391831
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of a newly developed 13-valent pneumococcal conjugate vaccine in a mouse model.
Park C; Kwon EY; Choi SM; Cho SY; Byun JH; Park JY; Lee DG; Kang JH; Shin J; Kim H
Hum Vaccin Immunother; 2017 May; 13(5):1169-1176. PubMed ID: 27960627
[TBL] [Abstract][Full Text] [Related]
18. Use of highly encapsulated Streptococcus pneumoniae strains in a flow-cytometric assay for assessment of the phagocytic capacity of serotype-specific antibodies.
Jansen WT; Gootjes J; Zelle M; Madore DV; Verhoef J; Snippe H; Verheul AF
Clin Diagn Lab Immunol; 1998 Sep; 5(5):703-10. PubMed ID: 9729539
[TBL] [Abstract][Full Text] [Related]
19. Comparison of an opsonophagocytic assay and IgG ELISA to assess responses to pneumococcal polysaccharide and pneumococcal conjugate vaccines in children and young adults with sickle cell disease.
Vernacchio L; Romero-Steiner S; Martinez JE; MacDonald K; Barnard S; Pilishvili T; Carlone GM; Ambrosino DM; Molrine DC
J Infect Dis; 2000 Mar; 181(3):1162-6. PubMed ID: 10720547
[TBL] [Abstract][Full Text] [Related]
20. [An immunoenzymatic test for IgG antibody levels against 10 serotypes of Streptococcus pneumoniae].
Leal-Esteban LC; Rojas JL; Jaimes AL; Montoya JD; Montoya NE; Leiva L; Trujillo-Vargas CM
Biomedica; 2012; 32(1):92-102. PubMed ID: 23235791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
